An interventional study of Multimedia Protocol about Asthma Control in Bronchial Asthma, Childhood Asthma and Climate Change, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 7 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Mansoura University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Asthma with a site in Egypt — 10 open to participants now, 11 under way, 1 of them phase 3. Asthma · Egypt.
Among the 42 studies in Asthma with a site in Egypt, this one is the 13th largest by enrollment of the 25 interventional ones that give a count, is one of 10 that started in 2024, is one of 17 with no phase, and was the 30th registered.
4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.
Browse Asthma studies →10 of the 42 studies in Asthma with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–30 · Women only
AstraZeneca · Sites in Egypt, Argentina, Mexico and 4 more countries
Ages 18+
Sohag University · Sites in Egypt
Ages 4–12 · Healthy volunteers
Sohag University · Sites in Egypt
Ages 2–18 · Healthy volunteers
Sohag University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.
This study: 7 Years to 11 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 4 · Phase 4 2
First in 2012; this study’s year is marked. 10 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 65 is below the median of 79 across 3,346 interventional studies indexed under Asthma.
Median enrollment 65 across the 25 interventional studies, 137 across the 17 observational. Of the 26 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 42 have an industry lead sponsor. The 10 most frequent:
Mansoura University is the lead sponsor of 1,121 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Mansoura University has 3 studies filed under Asthma — fewer than ten, so there is no comparison to draw.
3 of the studies in Asthma with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07730047Shaimaa Ali MohammedNLR, ELR and SII Index as Biomarkers of Asthma Control | 2027-01-01 |
| NCT07896291Sohag UniversityPrevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University Hospital | 2027-03-01 |
| NCT07245576AstraZenecaAssess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis | 2027-04-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 42 studies in Asthma with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effect of multimedia protocol about asthma control on asthmatic children's adaptation in the era of climate changes.
In fact, asthma has evolved into a global public health crisis affecting millions of people worldwide . It is one of the most prevalent chronic diseases, with a substantial burden on individuals, families, healthcare systems, and societies as a whole . Asthma not only leads to missed school and work but can also result in severe health emergencies and even death, especially in children . This burden is on the rise, with millions already affected and projections of millions more to come . Furthermore, the complex interplay of genetic, environmental, and lifestyle factors contributing to asthma's development adds to the urgency of addressing this issue . Importantly, the impact of global climate change, with its extreme weather events and increased air pollution, poses an additional threat to asthma sufferers, making it imperative to implement climate change and asthma adaptation measures . The problem's significance is compounded by the vulnerability of children to these environmental changes and the need for innovative strategies like educational multimedia to raise awareness and provide effective interventions. Addressing this multifaceted problem is essential for the well-being of individuals and communities worldwide. Therefore, this study aims to evaluate the effect of multimedia protocol about asthma control on asthmatic children's adaptation in the era of climate.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Multimedia Protocol about Asthma Control on Asthmatic Children's Adaptation in the Era of Climate Changes
Behavioral: Multimedia Protocol about Asthma Control
Addressing this multifaceted problem is essential for the well-being of individuals and communities worldwide. Therefore, this study aims to evaluate the effect of multimedia protocol about asthma control on asthmatic children's adaptation in the era of climate.
Children's Knowledge, Attitudes toward environmental protection, and adaptive asthma self-management behaviors
Tool I: A Questionnaire Sheet for Asthmatic Children and their Mothers. This tool will be developed by researcher based on the study aim and after reviewing the related literatures. It will consist of four part as follows Part One: Sociodemographic Characteristics of Children and their Mothers Part Two: The Child's Clinical Data Part Three: Child's Knowledge Regarding Climate Change and Bronchial Asthma Part Four: Child's Attitudes toward environmental protection and Adaptive Asthma Self Management Behaviors in the Context of Climate Change
Time frame: baseline for part one and two; at baseline, immediately after, and at 3 months later as a follow up for part three and attitude domain in part four; at baseline and at 3 month follow up for adaptive behavior domain in part four.
Childhood asthma control
Tool II; Childhood Asthma Control Test (C-ACT) A valid test that consists of seven questions which aims to assess asthma control in children 4-11 years old and the effects of asthma on daily functioning.
Time frame: baseline and at 3 months later as a follow up for each child
Tool III: Childhood Asthma Attack Severity Scale (C-AASS)
The tool consists of seven indicators assessing different dimensions of asthma attack severity. These include the duration of the last asthma attack, severity of breathing difficulty, intensity of cough or wheezing, impact of the attack on the child's physical activity, effect on sleep, frequency of rescue inhaler use, and the need for medical consultation, emergency department attendance, or hospital admission.
Time frame: at baseline and at 3 months follow up for each child
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2024 to primary completion in Jul 2026, 22 months.
Of 601 non-industry interventional studies with no phase under Asthma, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's 22 months is close to that.
Counting every sponsor, half of 651 studies reached it within 23 months; a quarter within 10 and three quarters within 47.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: start Jul 2025 → Sep 2024, primary completion Jan 2026 → Jul 2026 and completion Sep 2026 → Aug 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.